Back to blogIndustry Insights

Understanding PHI Access Monitoring Beyond EHR Audit Logs

||4 min read
Share
Blue-toned digital dashboard with glowing data streams, shield icon, and layered medical record panels.

Ready to slash administrative burden?

Let's have a 15-minute call to discuss our compliance and documentation platforms.

Let's Talk

See What EHR Audit Logs Miss

EHR audit logs are an important compliance record, but they are not a complete PHI access monitoring strategy. A log may show that someone opened a patient record. By itself, though, that activity does not explain whether the access was expected, appropriate, or part of a larger pattern that needs attention.

For privacy and compliance teams, the challenge is volume. There are many access events to review and limited time to investigate them. We help organizations look beyond raw log data so they can better separate routine care activity from possible snooping, misuse, or policy concerns. September is a practical time to review these processes before year-end compliance reviews, staffing changes, and planning work begin.

Move From Raw Audit Data to PHI Access Monitoring

PHI access monitoring is an ongoing process, not a one-time log check. It means reviewing access activity, identifying risk signals, and prioritizing events that deserve a closer look. The goal is not to collect more data. It is to turn available data into clear, defensible oversight.

Context matters when reviewing an access event. We encourage teams to ask questions such as:

  • Does this access fit the user's role?
  • Is there a care relationship or expected work reason?
  • Did the access happen in an expected location or during a normal work schedule?
  • Does the activity fit established clinical workflows?
  • Is there a repeated pattern that deserves investigation?

A risk-based approach helps your team spend time where it matters most. Rather than manually reviewing every event, you can focus on activity that appears inconsistent with expected patient care or organizational policy. That does not mean every flagged event is improper. It means the event deserves informed human review.

Investigate Privacy Risk with Haystack iS

Haystack iS is our patient privacy monitoring solution for healthcare organizations that need to identify and investigate potentially inappropriate patient record access. It helps make EHR audit activity more actionable for privacy and compliance teams by bringing attention to unusual access patterns and potential privacy concerns.

Instead of treating audit logs as a long list of isolated clicks, teams can use monitoring signals to organize their review process. A focused workflow can help your organization identify which events may need more context, follow-up, or documentation.

Consistent PHI access monitoring can support:

  • Better visibility into patient record access activity
  • More focused use of privacy and compliance resources
  • Stronger documentation of review steps and findings
  • A more proactive process than periodic manual log checks alone

Flagged activity still requires appropriate investigation. We do not treat a signal as proof of wrongdoing. Your organization's policies, clinical workflows, and the facts of each situation all matter before conclusions are made.

Connect Access Signals to Drug Diversion Risk

Patient privacy concerns and drug diversion concerns can overlap in healthcare settings, but they are not the same issue. An unusual record access event may be relevant to privacy oversight. Medication-related activity may point to a separate question that requires a diversion-focused investigation.

DetectRx is our drug diversion monitoring solution. It helps organizations surface patterns that may warrant review for possible controlled substance diversion or medication misuse. This gives compliance, pharmacy, security, and clinical leadership a way to focus on medication-related risk signals without treating those signals as final findings.

A connected compliance program recognizes that different concerns call for different review paths. Privacy monitoring should remain focused on access to patient information. Drug diversion monitoring should focus on medication activity. When the right teams can review the right signals, your organization is better prepared to investigate concerns with care and consistency.

Safeguard Documentation Workflows with Dragon Copilot

Microsoft Dragon Copilot fits into the clinical documentation workflow. AI-assisted documentation and speech recognition can help clinicians capture information more efficiently while supporting documentation quality and workflow consistency.

Dragon Copilot is not a PHI access monitoring tool, a privacy surveillance tool, or a drug diversion monitoring solution. Its place in the broader conversation is different. Documentation, access, privacy, and compliance are connected parts of daily clinical operations, and changes in one workflow can affect the others.

When introducing AI-enabled documentation workflows, we recommend planning for:

  • Role-appropriate access
  • Staff education and clear expectations
  • Approved use policies
  • Alignment with organizational privacy and security requirements

Our expert-guided implementation approach helps organizations consider workflow planning alongside the technology itself. Clear governance helps staff understand how new documentation tools fit within existing responsibilities and organizational standards.

Build a Defensible PHI Access Monitoring Program

EHR audit logs provide evidence, but effective PHI access monitoring requires context, prioritization, investigation workflows, and consistent oversight. A useful program helps your team identify potential patient privacy concerns without getting buried in routine access activity.

As you review your processes this fall, consider whether your organization can efficiently investigate higher-risk signals and address medication-related concerns without relying only on manual audit log review. The strongest approach keeps privacy monitoring, diversion monitoring, documentation workflows, and human investigation connected, while giving each concern the attention it requires.

Turn Privacy Signals Into Clear Next Steps

At Dictation Direct, we help healthcare organizations strengthen PHI access monitoring with Haystack iS, supporting focused review of potentially inappropriate access. Our team can discuss how the platform fits your privacy program and operational priorities. Sign up for a consultation today to discuss your needs and next steps.

Frequently Asked Questions

What is PHI access monitoring?

PHI access monitoring is the ongoing review of who accesses patient health information, why they accessed it, and whether the activity appears appropriate. It uses EHR audit data along with role, care relationship, location, timing, workflow, and behavior patterns to identify events that may need investigation.

Why are EHR audit logs not enough for PHI access monitoring?

EHR audit logs can show that a user opened a patient record, but they usually do not explain whether the access was necessary or appropriate. Effective monitoring adds context to help distinguish routine patient care activity from potential snooping, misuse, or policy concerns.

How can healthcare organizations identify potentially inappropriate patient record access?

Organizations can use a risk-based process that prioritizes unusual access patterns instead of manually reviewing every audit log event. Reviewers should consider the user's role, care relationship, work schedule, location, clinical workflow, and whether similar activity has occurred repeatedly.

What should happen when a PHI access event is flagged?

A flagged access event should receive informed human review and should not be treated as proof of wrongdoing. Privacy and compliance teams should gather relevant context, follow established investigation procedures, and document their review steps and findings.

What is the difference between PHI access monitoring and drug diversion monitoring?

PHI access monitoring focuses on whether patient information was accessed appropriately, while drug diversion monitoring focuses on medication activity that may indicate controlled substance diversion or misuse. The two areas can overlap in some investigations, but they require different risk signals, review processes, and internal teams.